White Papers

More Health Systems, More Data, More Access: Bridging Divides Among Specialty Pharmacy Stakeholders for the Benefit of Complex Patients 204 115 Shields Health Solutions

More Health Systems, More Data, More Access: Bridging Divides Among Specialty Pharmacy Stakeholders for the Benefit of Complex Patients

Drug manufacturers, payers and high-performing health system specialty pharmacies can leverage the size, scope and scale of a partner like Excelera to create efficiencies and improve the care of complex patients. Among the topics in this white paper:
Continuing Trends, Unexpected Changes: Optimizing Specialty Pharmacy in a New Environment 204 115 Shields Health Solutions

Continuing Trends, Unexpected Changes: Optimizing Specialty Pharmacy in a New Environment

This white paper describes the growth of health system specialty pharmacy in recent years, acknowledges the disruption caused by COVID-19, and discusses opportunities to optimize specialty pharmacy with data-driven solutions,…

How health system specialty pharmacies will help payers succeed in a value-based, data-driven future 204 115 Shields Health Solutions

How health system specialty pharmacies will help payers succeed in a value-based, data-driven future

This white paper highlights the importance of collaboration between payers and health systems and the benefits of carving in specialty pharmacy access at the point of care. These partnerships are…

How Specialty Pharmacy Networks are Redefining the Role of IDNs for Drug Manufacturers 204 115 Shields Health Solutions

How Specialty Pharmacy Networks are Redefining the Role of IDNs for Drug Manufacturers

This white paper points out that while complex patients usually receive care in a health system context, health systems often do not have access to specialty drugs those patients need. A network like Excelera connects drug manufacturers with health systems. • Drug access is an issue for health system specialty pharmacies. • Networks such as Excelera offer a high-quality, patient-centered specialty pharmacy solution. • Robust, real-world data from Excelera Network members, aggregated into one data feed, is one advantage.
Integrated Health Systems Can Leverage Their Strengths to Offer an Alternative to Traditional Pharmacy Benefit Management 204 115 Shields Health Solutions

Integrated Health Systems Can Leverage Their Strengths to Offer an Alternative to Traditional Pharmacy Benefit Management

This white paper provides a brief history of PBMs, describes what’s broken in the PBM industry, notes that the strengths of health systems support a realigned PBM model, and advises partnering with an outside resource when launching an integrated PBM. • The PBM industry has consolidated into a handful of misaligned and dominant players. • Consolidation has reduced competition and driven up prices. • Health systems can leverage their unique strengths to create a better PBM model.
Health Systems Working Together Strengthen Their In-House Specialty Pharmacy Capabilities and Optimize Patient Care 204 115 Shields Health Solutions

Health Systems Working Together Strengthen Their In-House Specialty Pharmacy Capabilities and Optimize Patient Care

This white paper provides background on the specialty pharmacy market, describes the role of health systems in specialty pharmacy care, acknowledges the challenges they face, and outlines the benefits of…

How Health Systems Can Optimize Revenue Streams and Improve the Patient Experience by Providing Home Infusion Pharmacy Services 204 115 Shields Health Solutions

How Health Systems Can Optimize Revenue Streams and Improve the Patient Experience by Providing Home Infusion Pharmacy Services

This white paper describes the home infusion opportunity, outlines factors to consider in deciding whether to launch a home infusion program, and recommends resources. A case study describing an Excelera Home Infusion Solutions engagement is included. • Home infusion is a growing category. • Many health systems find that home infusion aligns with clinical and financial goals. • A consultant can help health systems get to market faster as they develop their in-house home infusion expertise.